The prognostic power of metabolic syndrome (MetS) in patients with diabetes has been studied with inconsistent results depending on the definition of MetS. To clarify the best combination of MetS components to predict future cardiovascular disease (CVD) events, we estimated CVD risk in Japanese patients with type 2 diabetes according to MetS components. Methods: Patients were categorized according to the presence three MetS components in addition to hyperglycemia. hypertension, dyslipidemia and excess waist circumference (WC) (according to either Japanese or Asian cut-off values). Hazard ratios for CVD events were compared in patients with various categories of MetS components. Results: At least two components of MetS were required for a significantly elevated risk for CVD; however, component combinations with significantly increased risk differed depending on gender or the WC cut-off value. Any two among 1) excess WC (men ≥ 90 cm, women ≥ 80 cm); 2) hypertension (systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg or use of an antihypertensive agent); and 3) dyslipidemia (triglycerides ≥ 150 mg/dL or HDL-cholesterol 40 mg/dL or use of drug treatment) could be used to identify significantly higher risk (approximately twice) for CVD regardless of gender.
Introduction
Patients with diabetes are at greater risk for cardiovascular disease (CVD) than non-diabetic subjects, and metabolic syndrome (MetS), a constellation of multiple cardiometabolic risk factors, is strongly asso-ciated with increased risk of CVD events; however, previously, we found that the diagnosis of MetS had only a limited prognostic value for future CVD events in Japanese patients with type 2 diabetes [1] [2] [3] . Since that time many reports have also addressed the issue of whether a diagnosis of MetS is predictive in patients with diabetes, reflecting the need to identify diabetic patients at very high risk for CVD events in clinical settings; unfortunately, the results have been inconsistent [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . Some studies [5] [6] [7] 10) revealed that the clinical relevance of a diagnosis of MetS as a predictor of CVD morbidity and mortality differs markedly among diabetic patients, depending on the definition of MetS. Moreover, the contribution of each MetS component to cardiovascular risk was shown to significantly vary in the general population 14) .
These findings strongly suggest that various combinations of individual components of MetS could have substantially different contributions to CVD risk in diabetic patients. In fact, a recent cross-sectional study of 4020 German patients with type 2 diabetes 15) demonstrated considerably diverse odds ratios for established CVD according to heterogeneous clusters of traits; however, prospective studies evaluating the impact of specific combinations of MetS components on CVD risk in diabetic populations are scarce, although such a study in the general population has been published recently 16) . Such information would be useful for screening patients at extremely high risk of CVD as well as for improving the definition of MetS for a diabetic subgroup. For this purpose, we determined the prevalence of various combinations of MetS components among Japanese patients with type 2 diabetes and estimated the risks of CVD presented by these components in this patient group.
Methods
The Japan Diabetes Complications Study (JDCS) is a nationwide multi-center prospective study of type 2 diabetic patients 17) . In 1996, 2205 patients aged 40 − 70 years with previously diagnosed type 2 diabetes but no CVD were registered. The detailed protocol of the JDCS has been described previously 17) . Of the 2205 patients, 1424 (771 men and 653 women, mean age; 58.4 7.4 years) with a complete set of data, including the parameters necessary to satisfy the World Health Organization (WHO) 18) and the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP ) 19) criteria for the definition of MetS at baseline, were prospectively followed for 8 years for fatal/non-fatal coronary heart disease (CHD) and stroke events. CHD events consisted of angina pectoris and fatal/non-fatal acute myocardial infarction. A detailed definition of CHD and stroke events was previously described 1) . CHD and stroke events (hereafter referred to as CVD) identified during follow-up were confirmed by at least two members of the experts committee who were blinded as to risk factor status and the other member's diagnosis. The JDCS protocol was conducted according to the Declaration of Helsinki and received approval from the institutional review board. All participants gave written informed consent.
Thresholds for individual risk factors were adopted from the Japanese definition of MetS 20) , which is similar to that of IDF 21) with the exception that hypertriglyceridemia and low HDL-cholesterolemia are combined as one component, i.e, 'dyslipidemia'. Since all subjects in this study had diabetes mellitus, 3 criteria other than an elevated fasting plasma glucose level ( 110 mg/dL) were used: (i) excess WC (male ≥ 85 cm, female ≥ 90 cm), (ii) hypertension (systolic blood pressure ≥ 130 mmHg and/or diastolic blood pressure ≥ 85 mmHg), and (iii) dyslipidemia (triglyceride 150 mg/dL and/or HDL-cholesterol 40 mg/ dL). MetS is defined as the presence of excess WC and two of the following three parameters: hypertension, dyslipidemia and elevated fasting plasma glucose 20) . Subjects using agents for hypertension or hyperlipidemia were considered to have either hypertension or hyperlipidemia according to the recent MetS criteria 19, 21) . The alternative WC cut-off values for general Asians, as decided by the WHO and the International Diabetes Federation (IDF) definition (male ≥ 90 cm, female ≥ 80 cm) 19, 21) , were used for additional evaluation.
Data are presented as the means SD or as a proportion unless otherwise specified. WC in each group was assessed by Wilcoxon's rank sum test. Cox regression analysis was used to calculate the age-adjusted hazard ratio and 95% confidence intervals (CI) of risk factors for CVD. The SAS software package (Version 9.0, Cary, NC) was used for all analyses. P 0.05 was considered significant.
Results

Distribution of Patients According to Status of Risk Factor Clustering
Baseline characteristics of the study patients are shown in Table 1 . Distribution of patients categorized by risk factor status employing either the Japanese or Asian WC cut-off is shown in Fig. 1 . Approximately 60 − 70%, 30 − 0% or 20 − 25% of all diabetic patients, including both males and females, had hypertension, dyslipidemia or both, respectively. When the Japanese WC cut-off value (male ≥ 85 cm, female ≥ 90 cm) was applied, the proportion of female patients with excess WC was much lower than that of male patients. Among all diabetic patients, the proportion of patients having all 3 risk factors (i.e. excess WC, hypertension and dyslipidemia) was 13% among men but only 3% among women. When the Asian WC cut-off value (male ≥ 90 cm, female ≥ 80 cm) was used instead of the Japanese cut-off value, the proportion of female patients with excess WC increased nearly 4 times (approx. from 10 to 37%) while the proportion of male patients decreased by half (approx. from 37 to 18%). Table 2 shows hazard ratios for CVD (i.e. CHD and/or stroke) events in patients in the individual and combined risk categories indicated in Fig. 1 compared to those not in these areas. For example, patients in area (b c) were compared to patients in other areas. Analysis was performed using either Japanese or Asian WC cut-off values. In general, especially in female patients, substantially greater risk assessment accuracy was achieved when using the Asian WC cut-off value than the Japanese valve, since a relatively large number of categories with significantly elevated hazard ratios were obtained when the Asian cut-off value was used. Moreover, hazard ratio values were generally higher when using the Asian WC cut-off value.
CVD Risk of Patients in Individual and Combined Risk Category
When the risk for patients included in an individual category (i.e., a b, c, d, e, f, or g) was calculated separately from risks for patients not included in that particular area, male patients with all three MetS components (i.e. area c) had a significantly increased risk, regardless of the WC threshold. Male patients in area f also had a significantly elevated risk, but only when the Asian WC cut-off value was applied; however, in female patients, none of the individual categories represented a significantly increased risk.
When risks in male patients included in combinations of two areas (i.e., (b c), (c d) or (c f )) were assessed and compared with those not included in such combinations of those areas, only men in areas were predictive of CVD events only in female patients when the Asian WC cut-off value was applied. When risks in patients included in a combination of four areas (b c d f ) were assessed, both male and female patients had significantly elevated hazard ratios when using the Asian cut-off value. The hazard ratio values were similar to those with combinations of two or three areas.
Discussion
The present analysis prospectively demonstrated in Japanese patients with type 2 diabetes that 1) at least two components of MetS in addition to hyperglycemia are required to have a significantly elevated CVD risk; 2) the combination of MetS components associated with a significantly elevated CVD risk is markedly different depending on gender and the WC cut-off value and 3) the combinations of MetS components with high hazard ratios for CVD did not completely agree with the current definitions of MetS. These findings imply that the current MetS criteria need to be modified when applied to patients with type 2 diabetes.
Although the clinical relevance in diagnosing MetS in diabetic subjects is still under debate 22) , a simple assessment tool for cardiovascular risk in patients with diabetes but without an elevated LDL cholesterol level or who do not smoke is greatly needed in clinical settings, as demonstrated by the numerous recent studies that compared the hazard ratio for CVD between diabetic patients with and without MetS 1, 2, 4-13) ; unfortunately, the results were inconsistent.
Some of these studies concluded that MetS diagnosed by the current definitions has a considerable role in the increased CVD risk in patients with type 2 diabetes 5, 6, 9, 12, 13) , and that the impact of diabetes itself on CVD risk is relatively limited without coex- isting MetS or its components 23) . In contrast, in Finnish women 11) and Singaporean men 24) , MetS diagnosed by existing criteria does not present a further risk of CVD in addition to that presented by type 2 diabetes per se. Likewise, combinations of any two MetS components were not significantly associated with higher mortality in Italian patients with type 2 diabetes 7, 25) and a single component of MetS was a more powerful predictor than the overall syndrome in Type 1 diabetic patients 26) . Similarly, a recent report of the United Kingdom Prospective Diabetes Study 4) also questioned the clinical value of diagnosing MetS for CVD risk stratification in patients newly diagnosed with type 2 diabetes.
These inconsistencies in previous prospective studies along with our current results suggest that the established definitions of MetS leave room for improvement when applied to diabetic patients. It also implies that specific combinations of MetS components that increase CVD risk in diabetic patients differ depending on the ethnic group; therefore, an ethnicity-specific definition of MetS might be necessary.
The current results also revealed gender differences in combinations of MetS components associated with higher CVD risks. In male patients, dyslipidemia had a relatively large prognostic value since area [c (d and/or f )] indicated a significantly elevated risk for CVD events. On the other hand, in female patients, hypertension was important, which was similar to the result reported in Chinese patients with type 2 diabetes 10) . A large gender difference was also seen in other cohorts 11, 24, 27) . Most studies did not stratify results by gender in their analysis, which is considered to be a of the low prognostic power of the established definition of MetS; however, the gender difference became insignificant when area (b c d f ) in Fig. 1 is considered.
The current results also indicated that the Asian WC cut-off value is more appropriate than the Japanese cut-off value, even for Japanese diabetic patients, for discriminating patients at high risk; however, WC per se was not indispensable for predicting CVD events in our patients despite the worldwide definition of IDF 21) as well as Japanese 20) definitions of MetS, as we reported previously 2) . The poor prognostic power of the IDF definition in diabetic subjects has also been reported for other ethnic groups, such as Hong Kong Chinese 5) , Native Americans 6) and Italians 7) . Lack of a rationale for excess WC as a mandatory component of MetS was also shown in recent studies of non-diabetic subjects 14, 28) . Table 3 shows the suggested definitions of MetS for Japanese patients with type 2 diabetes based on our current and previous results. This criteria is similar Table 2 . Hazard ratio of CVD events (CHD and/or stroke) in diabetic patients according to individual and combined risk categories indicated in Fig. 1 compared to to that of the American Heart Association/National Heart Lung and Blood Institute (AHA/NHLBI) 19) (revised version of NCEP-ATP ) but differs in terms of dyslipidemia. that is, an elevated triglyceride level and decreased HDL cholesterol level were treated as individual components in the AHA/NHLBI definition. We previously determined that hazard ratios of hypertriglyceridemia alone and hypertriglyceridemia or low HDL cholesterol were almost identical, but the latter covers more patients. These two indices are known to be frequently correlated and so could have greater prognostic power when combined. Monami and colleagues 8) suggested that a MetS diagnosis based only on the unweighted number of components present in each patient, without considering each specific combination, could be inadequate to predict the risk level because a different risk profile is determined by different combinations of metabolic alterations. Although our current results principally support their conclusion, we still consider that using area (b c d f ) in Fig. 1 as a definition of MetS has merit in clinical settings because 1) the hazard ratios are similar (or even higher in female patients) to other significant combinations, 2) it can be used regardless of patient gender, 3) it covers more subjects than combinations of two or three areas among b, c, d and f, and 4) it is simple and easy to remember.
The current study has several strengths and limitations. The strengths include the nationwide multicentered setting and prospective design, which enabled us to assess the predictability of a CVD event. In addition, all institutes that participated are university or large general hospitals; therefore, the quality of risk evaluation and the accuracy of CVD diagnosis were excellent. A limitation is that the results may only be applicable to Japanese patients with type 2 diabetes. As described above, ethnicity can be considered an important factor for determining CVD risk in diabetic subjects as well as in the general population, so the clinical significance of MetS should be determined separately in each ethnic group. In addition, we do not have sufficient data on mortality, which needs to be determined in the future. We did not determine different cut-off values for blood pressure and serum lipids since their cut-off values have been well-established in many guidelines, unlike WC.
In conclusion, Japanese diabetic patients with two or more features of MetS with excess WC according to the Asian cut-off value (male ≥ 90 cm, female ≥ 80 cm), hypertension and dyslipidemia have a significantly elevated CVD event risk. Nevertheless, the rationale was weak for including WC as a mandatory component when evaluating CVD risk despite existing definitions of MetS. The definition of MetS should be modified to provide better prognostic value in clinical settings of diabetes management. Table 3 . Suggested definition of MetS for Japanese patients with type 2 diabetes for predicting future CVD events Patients with two or more of the following 1) Excess WC: men ≥ 90 cm, women ≥ 80 cm 2) Hypertension: systolic blood pressure ≥ 130 mmHg, diastolic blood pressure ≥ 85 mmHg or use of an agent for this condition 3) Dyslipidemia: triglyceride ≥ 150 mg/dL and/or HDL-cholesterol 40 mg/dL or use of an agent for this condition
